2022 annual financial data
Heron Therapeutics 2022 Operating margin
Direct answer
Operating margin was -162.21%.
Operating income was -174,658,000 USD and net income was -134,516,000 USD.
Operating cash flow was -146,912,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 107,672,000 USD
- Operating income
- -174,658,000 USD
- Net income
- -134,516,000 USD
- Operating cash flow
- -146,912,000 USD